Minakem Header W48

Minakem Header W48

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Filters

Reset Filter

All Developments

Product Type

Companies

Complix

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Complix Discovery Development Agreement Jiangsu Develop Alphabody Therapeutics

Details:

Under the terms of the agreement, Complix has granted an exclusive license to Nhwa to develop, manufacture and commercialize the CPABs resulting from this collaboration in Greater China.

Lead Product(s): Alphabody Therapeutics

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: Discovery Product Type: Large molecule

Partner/Sponsor/Collaborator: Jiangsu Nhwa Pharmaceutical

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement July 28, 2021

ASK
US

Upload
your Pipeline Activity

Confo Therapeutics

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Confo Therapeutics Awarded EUR 1M VLAIO Grant for Pre-Clinical Development of CFTX-1554

Details:

The grant covers clinical trial application-enabling studies to further characterize the pharmacology and safety of CFTX-1554 and the development of appropriate manufacturing protocols and translational biomarker studies to examine the mechanism of action of AT2R modulation.

Lead Product(s): CFTX-1554

Therapeutic Area: Neurology Product Name: CFTX-1554

Highest Development Status: Discovery Product Type: Undisclosed

Partner/Sponsor/Collaborator: Flanders Innovation & Entrepreneurship

Deal Size: $1.2 million Upfront Cash: Undisclosed

Deal Type: Funding March 30, 2021

ASK
US

Upload
your Pipeline Activity

POST ENQUIRY